%0 Generic
%T A randomized, multicenter, double-blind, placebo (PBO)-controlled phase III study of paclitaxel (PTX) with or without ramucirumab (IMC-1121B; RAM) in patients (pts) with metastatic gastric adenocarcinoma, refractory to or progressive after first-line therapy with platinum (PLT) and fluoropyrimidine (FP).
%A Wilke, Hansjochen
%A Cunningham, David
%A Ohtsu, Atsushi
%A Nuber, Ulrike
%A Bruns, Rolf
%A Schmitt-Bormann, Beate
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2012
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation